UNSPSC 51101926: Chloroguanide

This classification denotes a dihydrofolate reductase inhibitor and antimalarial agent, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 6T04V14CU9. European Medicines Agency schedules Chloroguanide hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04062MIG. Chloroguanide hydrochloride generally arises in the molecular formula C11H17CL2N5. The term 'chloroguanide hydrochloride' is a United States Adopted Name designation. SMILES: CLC1CC(N(/C(=N/C(C)C)N)C(=N)N)CCC1CL.CL.

UNSPSC 51101926 Chloroguanide is a Commodity code covering pharmaceutical active ingredients and specialty drugs, though recent state and local procurement activity under this code shows minimal alignment with the nominal category. State and local governments soliciting under this code are purchasing finished pharmaceutical products—primarily antimicrobial and emergency-response medications—rather than chloroguanide as an active ingredient. Issuing bodies include state departments of public health and county government health authorities, typically sourcing through cooperative purchasing consortia (such as MMCAP Infuse) or competitive sealed bids to supply community health programs, emergency preparedness initiatives, and public health stockpiles.

Recent activity appears concentrated in the Southeast and Midwest. The Illinois Department of Public Health awarded a $2,999,999.11 piggyback pharmaceutical contract through MMCAP Infuse to Chartwell Rx LLC in August 2026 for Doxycycline Hyclate 100mg tablets and Ciprofloxacin Hydrochloride 500mg tablets, with an initial 12-month term and two renewal options (IFB 26482DPHPREPDB53392). Seminole County, Florida issued an IFB (60459723LAS) in June 2026 for 1,900 units of Naloxone and 800 Safe Drug Deactivation Systems annually with quarterly deliveries, initial two-year term, and one-year renewal option; response deadline was July 26, 2026. Both opportunities required vendor compliance with drug-free workplace certification, E-Verify eligibility verification, and specific insurance coverage. The code shows limited recent state and local solicitation volume; opportunities posted are weighted toward emergency medical supplies and infectious-disease medications rather than chloroguanide-specific procurement.